Anti-Human CD55/DAF Polyclonal Antibody (HY307014)

Name: Anti-Human CD55/DAF Polyclonal Antibody
Brand: abinScience
SKU: HY307014
Price: 168 USD
Availability: InStock

Datasheet Share product Copy info

Price(USD):

Spec:

50ug
100ug

Number:

Get quote

Overview
Images
References
Datasheet
SDS

Overview

Catalog No.

HY307014

Description

Anti-CD55 Polyclonal Antibody (HY307014) is a rabbit polyclonal antibody detecting CD55 in ELISA, IHC, WB. Suitable for Human and Pongo pygmaeus.

Highlights

●Affinity Purified — Minimal background and high purity for reliable results.
●Multi-Application — Validated across multiple applications.

Species reactivity

Human

Applications

ELISA, IHC, WB

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Immunogen

E. coli - derived recombinant Human CD55 (Asp35-Gly285).

Target

Complement decay-accelerating factor, CR, DAF, CD55

Purification

Purified by antigen affinity column.

Accession

P08174

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information

Application	Dilution
ELISA	1:5000-1:20000
IHC	1:50-1:500
WB	1:500-1:2000

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Background

Complement decay-accelerating factor (CD55) is a ~41 kDa protein. This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade. Inhibits complement activation by destabilizing and preventing the formation of C3 and C5 convertases, which prevents complement damage.

1. Ward, T. et al. (1994) The EMBO journal 13, 5070-4. PMID: 7525274

2. Ozen, A. et al. (2017) The New England journal of medicine 377, 52-61. PMID: 28657829

Note

For research use only.

Images

References

Datasheet